ENDEAVOUR SILVER CORP (EXK)

CA29258Y1034 - Common Stock

4.46  -0.04 (-0.89%)

After market: 4.5 +0.04 (+0.9%)

Fundamental Rating

3

Overall EXK gets a fundamental rating of 3 out of 10. We evaluated EXK against 157 industry peers in the Metals & Mining industry. Both the profitability and financial health of EXK have multiple concerns. EXK is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

EXK had negative earnings in the past year.
In the past year EXK had a positive cash flow from operations.
EXK had positive earnings in 4 of the past 5 years.
Of the past 5 years EXK 4 years had a positive operating cash flow.

1.2 Ratios

With a Return On Assets value of -4.82%, EXK is not doing good in the industry: 64.97% of the companies in the same industry are doing better.
EXK has a worse Return On Equity (-7.13%) than 64.33% of its industry peers.
The Return On Invested Capital of EXK (1.32%) is comparable to the rest of the industry.
EXK had an Average Return On Invested Capital over the past 3 years of 3.14%. This is significantly below the industry average of 8.31%.
Industry RankSector Rank
ROA -4.82%
ROE -7.13%
ROIC 1.32%
ROA(3y)2.53%
ROA(5y)-4.24%
ROE(3y)3.14%
ROE(5y)-5.8%
ROIC(3y)3.14%
ROIC(5y)N/A

1.3 Margins

EXK's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 3.98%, EXK perfoms like the industry average, outperforming 51.59% of the companies in the same industry.
Looking at the Gross Margin, with a value of 17.57%, EXK is in line with its industry, outperforming 54.14% of the companies in the same industry.
EXK's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.98%
PM (TTM) N/A
GM 17.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y50.95%
PM growth 5YN/A
GM growth 3Y-3.31%
GM growth 5Y50.27%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXK is destroying value.
EXK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EXK has been increased compared to 5 years ago.
The debt/assets ratio for EXK has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 2.97 indicates that EXK is not a great score, but indicates only limited risk for bankruptcy at the moment.
EXK's Altman-Z score of 2.97 is in line compared to the rest of the industry. EXK outperforms 56.05% of its industry peers.
EXK has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
EXK's Debt to Equity ratio of 0.20 is in line compared to the rest of the industry. EXK outperforms 47.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 2.97
ROIC/WACC0.13
WACC9.85%

2.3 Liquidity

EXK has a Current Ratio of 1.39. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.39, EXK is not doing good in the industry: 77.07% of the companies in the same industry are doing better.
EXK has a Quick Ratio of 1.07. This is a normal value and indicates that EXK is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.07, EXK is not doing good in the industry: 68.15% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.07

6

3. Growth

3.1 Past

The earnings per share for EXK have decreased strongly by -120.00% in the last year.
EXK shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.99% yearly.
The Revenue has decreased by -4.65% in the past year.
Measured over the past years, EXK shows a small growth in Revenue. The Revenue has been growing by 6.42% on average per year.
EPS 1Y (TTM)-120%
EPS 3Y25.99%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y14.05%
Revenue growth 5Y6.42%
Sales Q2Q%8.11%

3.2 Future

EXK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 189.41% yearly.
EXK is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.21% yearly.
EPS Next Y-261.6%
EPS Next 2Y304.5%
EPS Next 3Y189.41%
EPS Next 5YN/A
Revenue Next Year9.99%
Revenue Next 2Y34.23%
Revenue Next 3Y30.21%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

2

4. Valuation

4.1 Price/Earnings Ratio

EXK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 13.63, EXK is valued correctly.
Based on the Price/Forward Earnings ratio, EXK is valued a bit cheaper than 70.70% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 24.00, EXK is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 13.63

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXK is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.04

4.3 Compensation for Growth

EXK's earnings are expected to grow with 189.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y304.5%
EPS Next 3Y189.41%

0

5. Dividend

5.1 Amount

No dividends for EXK!.
Industry RankSector Rank
Dividend Yield N/A

ENDEAVOUR SILVER CORP

NYSE:EXK (11/22/2024, 8:04:00 PM)

After market: 4.5 +0.04 (+0.9%)

4.46

-0.04 (-0.89%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.10B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 13.63
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.82%
ROE -7.13%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.98%
PM (TTM) N/A
GM 17.57%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.39
Quick Ratio 1.07
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-120%
EPS 3Y25.99%
EPS 5Y
EPS Q2Q%
EPS Next Y-261.6%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-4.65%
Revenue growth 3Y14.05%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y